Incidence, risk factors, and outcomes of recurrent focal segmental glomerulosclerosis in pediatric kidney transplant recipients: A systematic review and meta‐analysis

Abstract

AbstractBackgroundFocal segmental glomerulosclerosis is the most prevalent acquired kidney disease leading to end‐stage renal disease in children and has a propensity for recurring in the transplanted kidney. The recurrence of FSGS after kidney transplantation in children varies greatly. In addition, the risk factors and outcomes of recurrence of FSGS remain controversial. This study evaluated the recurrence rate, risk factors, and prognosis of FSGS after kidney transplantation in order to provide advice and assistance in clinical decision‐making for pediatric kidney transplantation.MethodsPubMed, Embase, Web of Science, CNKI, and other databases were searched from the establishment of the repository to March 2022. We extracted data on incidence, risk factors, and outcomes.ResultsThe results showed that the recurrence rate of primary FSGS in children after renal transplantation was 48% (95% CI 36%–59%) and the recurrence rate of FSGS (all forms) was 35% (95% CI 17%–52%). The graft loss rate of primary FSGS in children after kidney transplantation was 29% (95% CI 17%–42%) and the graft loss rate of FSGS (all forms) was 29% (95% CI 4%–62%). 57% (95% CI 42%–73%) of pediatric patients with recurrent primary FSGS showed complete remission. Risk factor analyses showed that age of onset (SMD .69, 95% CI .20–1.19, p = .006) was related to the recurrence of primary FSGS, whereas the living related donor was not a risk factor for recurrent primary FSGS in pediatrics after kidney transplantation (OR 1.22, 95% CI .48–3.10, p = .674).ConclusionsThe recurrence rate and graft loss rate of FSGS in children after kidney transplantation were relatively high. Age at onset was associated with a risk for recurrent primary FSGS, whereas the living related donor was not a risk factor for recurrent FSGS in pediatric kidney recipients.